Vigo-Pelfrey C, Schenk D, Lannfelt L, O'Neill C (1994) Increased betaamyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease
APP670/671 mutation. FEBS Lett 354:274 –278.
Karni R, Mizrachi S, Reiss-Sklan E, Gazit A, Livnah O, Levitzki A (2003) The
pp60c-Src inhibitor PP1 is non-competitive against ATP. FEBS Lett
537:47–52.
Kibbey MC, Jucker M, Weeks BS, Neve RL, Van Nostrand WE, Kleinman
HK (1993) beta-Amyloid precursor protein binds to the neuritepromoting IKVAV site of laminin. Proc Natl Acad Sci U S A
90:10150 –10153.
Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel
M, Mautino J, Vigo FS, Sommer B, Yankner BA (2000) Amyloid beta
interacts with the amyloid precursor protein: a potential toxic mechanism
in Alzheimer's disease. Nat Neurosci 3:460 – 464.
Lu DC, Shaked GM, Masliah E, Bredesen DE, Koo EH (2003) Amyloid beta
protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann Neurol 54:781–789.
McGuire PG, Orkin RW (1987) Isolation of rat aortic endothelial cells by
primary explant techniques and their phenotypic modulation by defined
substrata. Lab Invest 57:94 –105.
Nizheradze K (2006) Concanavalin A, but not glycated albumin, increases
subendothelial deposition of von Willebrand factor in vitro. Endothelium
13:245–248.
Price JM, Chi X, Hellermann G, Sutton ET (2001) Physiological levels of
beta-amyloid induce cerebral vessel dysfunction and reduce endothelial
nitric oxide production. Neurol Res 23:506 –512.
Reddick RL, Zhang SH, Maeda N (1994) Atherosclerosis in mice lacking apo
E. Evaluation of lesional development and progression. Arterioscler
Thromb 14:141–147.
Rossjohn J, Cappai R, Feil SC, Henry A, McKinstry WJ, Galatis D, Hesse L,
Multhaup G, Beyreuther K, Masters CL, Parker MW (1999) Crystal
structure of the N-terminal, growth factor-like domain of Alzheimer
amyloid precursor protein. Nat Struct Biol 6:327–331.
Russo C, Dolcini V, Salis S, Venezia V, Violani E, Carlo P, Zambrano N, Russo T,
Schettini G (2002) Signal transduction through tyrosine-phosphorylated
carboxy-terminal fragments of APP via an enhanced interaction with Shc/
Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. Ann
N Y Acad Sci 973:323–333.
Scheinfeld MH, Roncarati R, Vito P, Lopez PA, Abdallah M, D'Adamio L
(2002) Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1)
binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor
protein (APP). J Biol Chem 277:3767–3775.
Scheuermann S, Hambsch B, Hesse L, Stumm J, Schmidt C, Beher D, Bayer
TA, Beyreuther K, Multhaup G (2001) Homodimerization of amyloid
precursor protein and its implication in the amyloidogenic pathway of
Alzheimer's disease. J Biol Chem 276:33923–33929.
Shoji M, Hirai S, Harigaya Y, Kawarabayashi T, Yamaguchi H (1990) The
amyloid beta-protein precursor is localized in smooth muscle cells of
leptomeningeal vessels. Brain Res 530:113–116.
Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S, Lo ̈wer A, Langer A,
Merdes G, Paro R, Masters CL, Mu ̈ ller U, Kins S, Beyreuther K (2005)
Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J 24:3624 –3634.
Sondag CM, Combs CK (2004) Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J Biol Chem 279:
14456 –14463.
Stamper HB Jr, Woodruff JJ (1976) Lymphocyte homing into lymph nodes:
in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Med 144:828 – 833.
Thomas T, Thomas G, McLendon C, Sutton T, Mullan M (1996) betaAmyloid-mediated vasoactivity and vascular endothelial damage. Nature
380:168 –171.
Van Nostrand WE, Melchor JP, Keane DM, Saporito-Irwin SM, Romanov
G, Davis J, Xu F (2002) Localization of a fibrillar amyloid betaprotein binding domain on its precursor. J Biol Chem
277:36392–36398.
Vehmas A, Lieu J, Pardo CA, McArthur JC, Gartner S (2004) Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment.
J Neuroimmunol 157:99 –110.
